Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
IRMD — IRadimed Corporation
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

JUL 31, 2026
REVENUE
$20.5M -6.9%
NET MARGIN
25.5% -1.0 PTS
EPS
$0.41 -10.9%
FREE CASH FLOW
$5.8M -27.0%

No summary has been written for this call yet.